ABC-transporters as stem-cell markers in brain dysplasia/tumor epilepsies
Lilliana Czornyj1, Alberto Lazarowski1
1Servicio de Neurologia, Hospital Juan P. Garraham, Combate de Los Pozos 1881(1245), CABA, Argentina.
Abstract:
ABC-transporters prevent the access of antiepileptic drugs into brain parenchyma, which partly explains why seizures are frequently refractory to AEDs treatment. Overexpression of ABC-transporters and stem-cell markers including CD34, have been detected in malformations of cortical development (MCD) and brain tumors. ABC-transporters are constitutively expressed during maturation of normal progenitor stem-cells and cancer stem-cells. These abnormal/immature cells of MCD or brain tumors play an active role in the epileptogenesis but the precise nature of this phenomenon is unclear. Irrespective of their property in the pharmacoresistance, ABCB1-transporter P-glycoprotein also plays a role in the membrane depolarization, suggesting that constitutive P-glycprotein overexpression in MCD and brain tumors could explain their epileptogeneic properties. MCD as wells as brain tumors arise from abnormal progenitor cells, where ABC-t together with others stem cell markers, could help to better identification of these abnormal progenitor cells and serve as biomarker of risk for seizure relapse after epilepsy surgery.
Insights
ABC-transporters hinder antiepileptic drug entry into the brain, contributing to treatment resistance. Their overexpression in developmental brain abnormalities and tumors may also drive seizure activity and indicate relapse risk.
Area of Science:
- Neuroscience
- Cell Biology
- Pharmacology
Background:
- ABC-transporters limit antiepileptic drug (AED) penetration into brain parenchyma, contributing to refractory epilepsy.
- Overexpression of ABC-transporters and stem cell markers like CD34 is observed in malformations of cortical development (MCD) and brain tumors.
- These transporters are normally expressed during progenitor stem cell maturation.
Purpose of the Study:
- To investigate the role of ABC-transporters in epileptogenesis associated with MCD and brain tumors.
- To explore ABC-transporters and stem cell markers as potential biomarkers for identifying abnormal progenitor cells and predicting seizure relapse risk.
Main Methods:
- Analysis of ABC-transporter and stem cell marker expression in MCD and brain tumors.
- Correlation of transporter expression with epileptogenic properties and clinical outcomes (e.g., seizure relapse).
Main Results:
- ABC-transporter overexpression is detected in abnormal progenitor cells within MCD and brain tumors.
- P-glycoprotein (ABCB1), an ABC-transporter, may contribute to membrane depolarization and epileptogenesis.
- ABC-transporters and stem cell markers show potential for identifying epileptogenic progenitor cells.
Conclusions:
- Constitutive overexpression of ABC-transporters in MCD and brain tumors may underlie their epileptogenic nature.
- ABC-transporters and stem cell markers could serve as biomarkers for identifying abnormal progenitor cells.
- These biomarkers may predict the risk of seizure recurrence after epilepsy surgery.
More Related Videos
10:59Generation and Characterization of Human Induced Pluripotent Stem Cell-derived Astrocytes Lacking Fragile X Messenger Ribonucleoprotein
Published on: June 6, 2025
08:04Derivation, Expansion, Cryopreservation and Characterization of Brain Microvascular Endothelial Cells from Human Induced Pluripotent Stem Cells
Published on: November 19, 2020
